CPT2 blocking peptide

CPT2 Antibody (N-term) Blocking Peptide

• Gene Names: CPT2; CPT1; IIAE4; CPTASE
• Synonyms: CPT2; CPT2 Antibody (N-term) Blocking Peptide; Carnitine O-palmitoyltransferase 2; mitochondrial; Carnitine palmitoyltransferase II; CPT II; CPT1; CPT2 blocking peptide

• Specificity: The synthetic peptide sequence used to generate the antibody was selected from the N-term region of human CPT2. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
• Form/Format: The synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml.
• Sequence Length: 658

• Cellular Location: Mitochondrion inner membrane; Peripheral membrane protein; Matrix side
• Preparation and Storage: Maintain refrigerated at 2-8 degree C for up to 6 months. For long term storage store at -20 degree C.

NCBI and Uniprot Product Information

• NCBI GI #: 416836
• NCBI GeneID: 1376
• UniProt Accession #: P23786; Q5SW68; Q9BQ26; B2R6S0
• Molecular Weight: 73,777 Da
• NCBI Official Full Name: Carnitine O-palmitoyltransferase 2, mitochondrial
• NCBI Official Synonym Full Names: carnitine palmitoyltransferase 2
• NCBI Official Symbol: CPT2
• NCBI Official Synonym Symbols: CPT1; IIAE4; CPTASE
• NCBI Protein Information: carnitine O-palmitoyltransferase 2, mitochondrial
• UniProt Protein Name: Carnitine O-palmitoyltransferase 2, mitochondrial
• Protein Family: Carnitine O-palmitoyltransferase
• UniProt Gene Name: CPT2
• UniProt Synonym Gene Names: CPT1; CPT II
• UniProt Entry Name: CPT2_HUMAN

NCBI Description

The protein encoded by this gene is a nuclear protein which is transported to the mitochondrial inner membrane. Together with carnitine palmitoyltransferase I, the encoded protein oxidizes long-chain fatty acids in the mitochondria. Defects in this gene are associated with mitochondrial long-chain fatty-acid (LCFA) oxidation disorders. [provided by RefSeq, Jul 2008]

Uniprot Description

CPT2: Defects in CPT2 are the cause of carnitine palmitoyltransferase 2 deficiency late-onset (CPT2D); also known as CPT-II deficiency or CPT2 deficiency. CPT2D is an autosomal recessive disorder characterized by recurrent myoglobinuria, episodes of muscle pain, stiffness, and rhabdomyolysis. These symptoms are triggered by prolonged exercise, fasting or viral infection and patients are usually young adults. In addition to this classical, late-onset, muscular type, a hepatic or hepatocardiomuscular form has been reported in infants. Clinical pictures in these children or neonates include hypoketotic hypoglycemia, liver dysfunction, cardiomyopathy and sudden death. Defects in CPT2 are the cause of carnitine palmitoyltransferase 2 deficiency infantile (CPT2DI). A disorder of mitochondrial long-chain fatty acid oxidation characterized by hepatic or hepato-cardio-muscular manifestations with onset in infancy. Clinical features include hypoketotic hypoglycemia, lethargy, seizures, hepatomegaly, liver dysfunction, cardiomegaly and dilated cardiomyopathy. Defects in CPT2 are the cause of carnitine palmitoyltransferase 2 deficiency lethal neonatal (CPT2D-LN); also known as lethal neonatal CPT-II deficiency. It is a lethal neonatal form of CPT2D. This rarely presentation is antenatal with cerebral periventricular cysts and cystic dysplastic kidneys. The clinical variability of the disease is likely attributed to the variable residual enzymatic activity. Defects in CPT2 are a cause of susceptibility to encephalopathy acute infection-induced type 4 (IIAE4). A severe neurologic complication of an infection. It manifests within days in otherwise healthy children after common viral infections, without evidence of viral infection of the brain or inflammatory cell infiltration. In affected children, high- grade fever is accompanied within 12 to 48 hours by febrile convulsions, often leading to coma, multiple-organ failure, brain edema, and high morbidity and mortality. The infections are usually viral, particularly influenza, although other viruses and even mycoplasma have been found to cause the disorder. Polymorphic variants in CPT2 can confer susceptibility to infection-induced encepalopathy. These variants do not cause classical carnitine palmitoyltransferase 2 deficiency, and patients harboring any of them are asymptomatic most of the time. However, they are prone to viral infection (high fever)-related encephalopathy (PubMed:21697855). Belongs to the carnitine/choline acetyltransferase family.

Protein type: Transferase; Mitochondrial; EC 2.3.1.21; Lipid Metabolism - fatty acid

Chromosomal Location of Human Ortholog: 1p32

Cellular Component: mitochondrial inner membrane; mitochondrion; nucleolus; nucleoplasm

Molecular Function: carnitine O-palmitoyltransferase activity

Biological Process: carnitine shuttle

Disease: Carnitine Palmitoyltransferase Ii Deficiency, Infantile; Carnitine Palmitoyltransferase Ii Deficiency, Late-onset; Carnitine Palmitoyltransferase Ii Deficiency, Lethal Neonatal; Encephalopathy, Acute, Infection-induced, Susceptibility To, 4